Bafna Pharma Declares Unaudited Q1 FY27 Results; Sets AGM Date

Bafna Pharmaceuticals Ltd announced its unaudited financial results for the first quarter ended June 30, 2026. The Board of Directors also approved the limited review report. The company has scheduled its 31st Annual General Meeting (AGM) for September 11, 2026, to be held via Video Conferencing. Book closure for the AGM will be from September 5 to September 11, 2026, with a cut-off date of September 4, 2026, for determining voting eligibility.